[A case of chronic hepatitis B who achieved clinical cure with pegylated interferon alfa intermittent and combination therapy]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang SY, Deng W, Li MH.
europepmc +1 more source
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers. [PDF]
BMC Pharmacol Toxicol, 2018 Costa MB +11 more
europepmc +1 more source
Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia. [PDF]
Am J Ophthalmol, 2019 Venkateswaran N +3 more
europepmc +1 more source
Pembrolizumab plus ipilimumab or pegylated interferon alfa-2b for patients with melanoma or renal cell carcinoma: take new drugs but keep the old? [PDF]
Ann Transl Med, 2019 Zibelman M, Plimack ER.
europepmc +1 more source
Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma. [PDF]
J Clin Oncol, 2018 Davar D +18 more
europepmc +1 more source
Interferon alfa-induced sarcoidosis resolving without drug withdrawal. [PDF]
JAAD Case Rep, 2016 Ortiz Salvador JM +4 more
europepmc +1 more source
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. [PDF]
Leukemia, 2019 Mascarenhas J +31 more
europepmc +1 more source